MedPath

High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma

Not Applicable
Active, not recruiting
Conditions
Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Acute Leukemia
Interventions
Other: Educational Intervention
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Registration Number
NCT03178617
Lead Sponsor
City of Hope Medical Center
Brief Summary

This randomized clinical trial studies how well a high-intensity intervention parenting program works in improving learning and school functioning in Latino children with acute leukemia or lymphoblastic lymphoma. A high-intensity intervention program may help doctors to see whether training parents or caregivers in specific parenting skills and "pro-learning" behaviors will result in better learning and school outcomes for Latino children with acute leukemia or lymphoblastic lymphoma. It is not yet known if a high-intensity intervention program is more beneficial than a standard of care lower intensity parenting intervention.

Detailed Description

PRIMARY OBJECTIVES:

I. Determine the effectiveness of an enhanced parenting intervention, high-intensity intervention program (HIP), on pediatric cancer survivors' learning and school health-related quality of life (HRQOL) outcomes up to 12 months post enrollment.

II. Determine the effectiveness of HIP on the "pro-learning" efficacy of parents of pediatric cancer survivors up to 12 months post enrollment.

III. Examine the extent to which the parent's increases in personal efficacy and use of "pro-learning" behaviors correlate with the child's school HRQOL and academic performance.

IV. Obtain preliminary data on the relationships between family stress and the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) with neurocognitive and health-related quality of life (HRQOL) outcomes in Latino children treated with CNS-directed therapies for cancer.

V. Conduct preliminary analysis on the interaction between family stress and the BDNF Met polymorphism when predicting cognitive and HRQOL outcomes in Latino children treated for cancer.

EXPLORATORY OBJECTIVES:

I. Explore the associations between neurocognitive performance and polymorphisms in candidate genes previously reported to explain cognitive variability in childhood cancer survivors (e.g., the catechol-O-methyltransferase Val158Met polymorphism and the nitric oxide synthase \[NOS3\] 894T allele) or involved in the stress response (e.g., the Serotonin transporter rs25531 and the Glucocorticoid receptor rs6190).

OUTLINE: Parents or caregivers are randomized to 1 of 2 arms.

ARM I: Parents or caregivers attend standard of care lower intensity intervention program (LIP) consisting of a meeting to review results of a neurocognitive evaluation and to discuss recommendations for optimal learning and school performance for 1 session.

ARM II: Parents or caregivers attend HIP consisting of individual parental skill training sessions with a bilingual therapist over 60-90 minutes every 2 weeks for a total of 8 sessions.

After study enrollment, patients are followed up for 12 months.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
214
Inclusion Criteria
  • PARENT/CAREGIVER: Adult primary caregiver of children treated for leukemia or lymphoblastic lymphoma (LL) and daily contact with the child
  • PARENT/CAREGIVER: One or both parents self-identify as Hispanic/Latino and the primary participating parent/caregiver is monolingual or bilingual Spanish speaking
  • CHILD: Children treated for acute leukemia (e.g. acute lymphoblastic leukemia [ALL], acute myeloid leukemia [AML]), LL, or other types of leukemia (if treated intensively) aged 5-12 years and their parents/caregivers
  • CHILD: Child has completed cancer treatment and is up to 10 years post-treatment
  • CHILD: Child understands English and is enrolled in school (but can be bilingual)
Exclusion Criteria
  • History of major psychiatric condition (e.g. psychosis) in parent or child; severe neurodevelopmental disorder in child (e.g. Down's syndrome)
  • Recent or current participation in educational/behavioral intervention study with similar focus

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm I (standard of care LIP)Educational InterventionParents or caregivers attend standard of care LIP consisting of a meeting to review results of a neurocognitive evaluation and to discuss recommendations for optimal learning and school performance for 1 session.
Arm I (standard of care LIP)Quality-of-Life AssessmentParents or caregivers attend standard of care LIP consisting of a meeting to review results of a neurocognitive evaluation and to discuss recommendations for optimal learning and school performance for 1 session.
Arm II (HIP)Educational InterventionParents or caregivers attend HIP consisting of individual parental skill training sessions with a bilingual therapist over 60-90 minutes every 2 weeks for a total of 8 sessions.
Arm II (HIP)Questionnaire AdministrationParents or caregivers attend HIP consisting of individual parental skill training sessions with a bilingual therapist over 60-90 minutes every 2 weeks for a total of 8 sessions.
Arm I (standard of care LIP)Questionnaire AdministrationParents or caregivers attend standard of care LIP consisting of a meeting to review results of a neurocognitive evaluation and to discuss recommendations for optimal learning and school performance for 1 session.
Arm II (HIP)Quality-of-Life AssessmentParents or caregivers attend HIP consisting of individual parental skill training sessions with a bilingual therapist over 60-90 minutes every 2 weeks for a total of 8 sessions.
Primary Outcome Measures
NameTimeMethod
Change in child's health-related quality of life school functioningBaseline up to 12 months

Measured by the parent-reported Pediatric Quality of Life Inventory school domain.

Change in parental efficacyBaseline up to 12 months

Measured by the Efficacy scale from the Parent Knowledge, Beliefs and Behaviors Questionnaire-3rd Revision (PBQ-R3).

Secondary Outcome Measures
NameTimeMethod
Objective academic performance (Child)Up to 12 months

Measured by WIAT: reading and math scores and classroom grades from school report cards.

Children's scores on other neurocognitive tests as assessed by learning, memory, and processing speedUp to 12 months
Attention performance (Child)Up to 12 months

Measured by the Conners Parent Report Attention subscale.

Knowledge of pro-learning parenting (Parent)Up to 12 months

Measured by PBQ-R3 Knowledge scale.

Parental reports of their children's HRQOL as measured by the PedsQL parent proxy questionnaireUp to 12 months
Frequency of pro-learning behaviors (Parent)Up to 12 months

Measured by the Parents' weekly time spent with child in pro-learning behaviors and activities.

Trial Locations

Locations (3)

City of Hope Medical Center

🇺🇸

Duarte, California, United States

Children's Hospital Los Angeles

🇺🇸

Los Angeles, California, United States

Children's Hospital of Orange County

🇺🇸

Orange, California, United States

© Copyright 2025. All Rights Reserved by MedPath